Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2015		Sep. 30, 2014
Cash Flows from Operating Activities:
Net loss	$ (1,592,144)		$ (1,532,712)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	39,760		36,473
Stock-based compensation expense	722,090		394,520
Changes in operating assets and liabilities:
Prepaid expenses	7,838		7,921
Inventory	66,611		0
Accounts payable and accounts payable – related parties	(677)		(15,257)
Accrued expenses and accrued expenses – related parties	25,086		(11,659)
Net Cash Used in Operating Activities	(731,436)		(1,120,714)
Cash Flows from Investing Activities:
Purchase of patents	(17,955)		(29,246)
Net Cash Used in Investing Activities	(17,955)		(29,246)
Cash Flows from Financing Activities:
Principal payments on notes payable	(40,516)		(51,841)
Issuance of notes payable	75,000		0
Issuance of common stock	676,000		1,222,250
Net Cash Provided by Financing Activities	710,484		1,170,409
Effect of Foreign Currency Exchange Rates	18,611		(3,872)
Net increase (decrease) in cash	(20,296)		16,577
Cash as of beginning of the period	140,496	[1]	81,856
Cash as of end of the period	120,200		98,433
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	1,006		909
NON-CASH FINANCING ACTIVITIES:
Financing of insurance policies	$ 49,964		$ 65,214

[1] The condensed consolidated balance sheet as of December 31, 2014 has been prepared using information from the audited consolidated balance sheet as of that date.